Brief: Aerovate Therapeutics Announces Range Of Expected Cash Dividend
07/04/2025 14:08
April 7 (Reuters) - Aerovate Therapeutics Inc AVTE.O: AEROVATE THERAPEUTICS ANNOUNCES RANGE OF EXPECTED CASH DIVIDEND IN CONNECTION WITH THE PROPOSED MERGER WITH JADE BIOSCIENCES AEROVATE THERAPEUTICS INC - CASH DIVIDEND EXPECTED TO BE IN RANGE OF $67.6 - 69.6 MILLION Source text: ID:nPn9bbfTsa Further company coverage: AVTE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million